Read Time:7 Second
FDA officials tell the Wall Street Journal that safety concerns around CBD may cause the agency to publish its first guidelines on cannabis-derived products.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
